Lv32
380 积分 2022-09-15 加入
Efficacy and Safety of Tirzepatide in Overweight and Obese Adult Patients with Type 1 Diabetes
1小时前
待确认
Semaglutide in Adults with Type 1 Diabetes and Obesity
1小时前
已完结
Prevalence of obesity and associated factors in the Brazilian population: a study of data from the 2013 National Health Survey
23小时前
已完结
Tolerability, pharmacokinetics and pharmacodynamics of the once-daily human GLP-1 analog liraglutide in Japanese healthy subjects: a randomized, double-blind, placebo-controlled dose-escalation study
11天前
已完结
Pharmacokinetics and safety of pirfenidone in individuals with chronic kidney disease stage G2 and G3a: A single-dose, Phase I, bridging study
26天前
已完结
[Current status and management of obesity in China]
1个月前
已完结
[Expert Consensus on Obesity Prevention and Treatment in China]
1个月前
已完结
Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes
1个月前
已完结
Mazdutide versus placebo in Chinese adults with type 2 diabetes
1个月前
已完结
Top product forecasts for 2026
1个月前
已关闭
皖公网安备34019202002308
